Rapt Therapeutics ( RAPT) skyrocketed
in a massive technical breakout today, rising over 17 % to close at $36.75
RAPT, from South San Francisco, Ca is on the cutting edge of cancer research in the 21'st century,
and is working on clinical trials for two of it's patented drugs,currently seeking FDA Initial Phase 1 Approval.
I have written about Rapt Therapeutics previously in 2019,
The stock is up over 300%, since it's initial public offering at $12.00 on Oct.31,2019
For the record, I have owned, and have been accumulating
this stock strongly since it's IPO, and would recommend purchase on any pullback.
You may not believe this.
I have an upside target for RAPT,of $1000.00 a share, within the next 5 years.
RAPT Last 36.75
THE_UNWIND
1/15/20
NEW YORK
in a massive technical breakout today, rising over 17 % to close at $36.75
RAPT, from South San Francisco, Ca is on the cutting edge of cancer research in the 21'st century,
and is working on clinical trials for two of it's patented drugs,currently seeking FDA Initial Phase 1 Approval.
I have written about Rapt Therapeutics previously in 2019,
The stock is up over 300%, since it's initial public offering at $12.00 on Oct.31,2019
For the record, I have owned, and have been accumulating
this stock strongly since it's IPO, and would recommend purchase on any pullback.
You may not believe this.
I have an upside target for RAPT,of $1000.00 a share, within the next 5 years.
RAPT Last 36.75
THE_UNWIND
1/15/20
NEW YORK
Ghi chú
1/17/20RAPT Closed at $46.96 on 1/16/20
Up another 28%... or $10.21
Strong Buy ! Support Now at $40.00 a share
Remember do your own due diligence.
This is not trading advise of any kind.Thank you.
THE_UNWIND
NEW YORK
Thông báo miễn trừ trách nhiệm
Thông tin và ấn phẩm không có nghĩa là và không cấu thành, tài chính, đầu tư, kinh doanh, hoặc các loại lời khuyên hoặc khuyến nghị khác được cung cấp hoặc xác nhận bởi TradingView. Đọc thêm trong Điều khoản sử dụng.
Thông báo miễn trừ trách nhiệm
Thông tin và ấn phẩm không có nghĩa là và không cấu thành, tài chính, đầu tư, kinh doanh, hoặc các loại lời khuyên hoặc khuyến nghị khác được cung cấp hoặc xác nhận bởi TradingView. Đọc thêm trong Điều khoản sử dụng.